Literature DB >> 28726062

Valproic Acid in Women and Girls of Childbearing Age.

Dorothy Gotlib1, Rachel Ramaswamy2, Jacob E Kurlander3, Alana DeRiggi4, Michelle Riba4.   

Abstract

PURPOSE OF REVIEW: The aim of this paper is to evaluate recent literature on valproic acid (VPA) in women and girls of childbearing age and to emphasize new findings. RECENT
FINDINGS: Recent research confirms VPAs teratogenicity and risk of hormone disruption. VPA exposure in utero increases the risk for a variety of major congenital malformations (MCMs), reduced IQ and behavioral problems. In girls and women, VPA increases the risk of hormone abnormalities, obesity, and polycystic ovarian syndrome (PCOS). Despite guidelines recommending caution, VPA use continues to be prescribed to reproductive-aged women and girls. Despite significant and well-documented risk, adherence to guidelines in VPA use in reproductive-aged girls and women remains low.

Entities:  

Keywords:  Childbearing; Guidelines; Pregnancy; Valproic acid; Women

Mesh:

Substances:

Year:  2017        PMID: 28726062     DOI: 10.1007/s11920-017-0809-3

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  54 in total

Review 1.  ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation.

Authors: 
Journal:  Obstet Gynecol       Date:  2008-04       Impact factor: 7.661

2.  The dilemma of treating young women with generalized epilepsy with sodium valproate and how to get out of it.

Authors:  Dieter Schmidt
Journal:  Seizure       Date:  2014-10-18       Impact factor: 3.184

Review 3.  Urgent global opportunities to prevent birth defects.

Authors:  Vijaya Kancherla; Godfrey P Oakley; Robert L Brent
Journal:  Semin Fetal Neonatal Med       Date:  2013-12-14       Impact factor: 3.926

4.  Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States.

Authors:  Suzanne M Gilboa; Cheryl S Broussard; Owen J Devine; Kara N Duwe; Audrey L Flak; Sheree L Boulet; Cynthia A Moore; Martha M Werler; Margaret A Honein
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-07-15       Impact factor: 3.908

5.  Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.

Authors:  Torbjörn Tomson; Dina Battino; Erminio Bonizzoni; John Craig; Dick Lindhout; Anne Sabers; Emilio Perucca; Frank Vajda
Journal:  Lancet Neurol       Date:  2011-06-05       Impact factor: 44.182

Review 6.  Neural tube defects, folate, and immune modulation.

Authors:  Kerina J Denny; Angela Jeanes; Kristin Fathe; Richard H Finnell; Stephen M Taylor; Trent M Woodruff
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2013-09

Review 7.  Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts.

Authors:  Kimford Meador; Matthew W Reynolds; Sheila Crean; Kyle Fahrbach; Corey Probst
Journal:  Epilepsy Res       Date:  2008-06-18       Impact factor: 3.045

Review 8.  Risks of neurobehavioral teratogenicity associated with prenatal exposure to valproate monotherapy: a systematic review with regulatory repercussions.

Authors:  Salvatore Gentile
Journal:  CNS Spectr       Date:  2014-02-26       Impact factor: 3.790

9.  Counseling of female veterans about risks of medication-induced birth defects.

Authors:  Eleanor Bimla Schwarz; Kristin Mattocks; Cynthia Brandt; Sonya Borrero; Laurie C Zephyrin; Harini Bathulapalli; Sally Haskell
Journal:  J Gen Intern Med       Date:  2013-07       Impact factor: 5.128

10.  Polycystic ovary syndrome in patients on antiepileptic drugs.

Authors:  Lakshminarayanapuram G Viswanathan; Parthasarathy Satishchandra; Bipin C Bhimani; Janardhan Yc Reddy; Batchu S Rama Murthy; Doddaballapura K Subbakrishna; Sanjib Sinha
Journal:  Ann Indian Acad Neurol       Date:  2016 Jul-Sep       Impact factor: 1.383

View more
  6 in total

1.  Photosensitive Epilepsy and Polycystic Ovary Syndrome as Manifestations of MERRF.

Authors:  Josef Finsterer
Journal:  Case Rep Neurol Med       Date:  2020-09-28

2.  Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017.

Authors:  Johanna Seifert; Fabienne Führmann; Marcel Sieberer; Waldemar Greil; Matthias A Reinhard; Rolf R Engel; Xueqiong Bernegger; Stefan Bleich; Susanne Stübner; Eckart Rüther; Sermin Toto; Renate Grohmann
Journal:  J Neural Transm (Vienna)       Date:  2021-05-11       Impact factor: 3.575

3.  Pharmacological inhibition of EZH2 disrupts the female germline epigenome.

Authors:  Lexie Prokopuk; Kirsten Hogg; Patrick S Western
Journal:  Clin Epigenetics       Date:  2018-03-05       Impact factor: 6.551

Review 4.  Research Progress on the Effect of Epilepsy and Antiseizure Medications on PCOS Through HPO Axis.

Authors:  Shuang Li; Linhai Zhang; Nian Wei; Zhenzhen Tai; Changyin Yu; Zucai Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-21       Impact factor: 5.555

5.  Borderline Personality Disorder "Discouraged Type": A Case Report.

Authors:  Lavinia Duică; Elisabeta Antonescu; Maria Totan; Gabriela Boța; Sînziana Călina Silișteanu
Journal:  Medicina (Kaunas)       Date:  2022-01-21       Impact factor: 2.430

6.  Twice Daily Prazosin and Valproic Acid in the Treatment of Flashbacks in PTSD.

Authors:  Kristy A Fisher; Heidi Kiziah; Clara L Villalba Alvarez
Journal:  Case Rep Psychiatry       Date:  2022-08-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.